These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 27342387

  • 1. Effects of therapeutic and supratherapeutic doses of oral tedizolid phosphate on cardiac repolarisation in healthy volunteers: a randomised controlled study.
    Flanagan S, Litwin J, Fang E, Prokocimer P.
    Int J Antimicrob Agents; 2016 Jul; 48(1):33-40. PubMed ID: 27342387
    [Abstract] [Full Text] [Related]

  • 2. A Phase 1, double-blind, 4-period crossover study to investigate the effects of pomalidomide on QT interval in healthy male subjects.
    Mondal SA, Assaf M, Liu L, O'Mara E.
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):251-8. PubMed ID: 26754679
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics, Safety, and Tolerability of Tedizolid Phosphate After Single-dose Administration in Healthy Korean Male Subjects.
    Kim Y, Kim A, Lee S, Choi SH, Lee DY, Song JS, Lee H, Jang IJ, Yu KS.
    Clin Ther; 2017 Sep; 39(9):1849-1857. PubMed ID: 28865799
    [Abstract] [Full Text] [Related]

  • 4. Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trials.
    Yang H, Laurenza A, Williams B, Patten A, Hussein Z, Ferry J.
    Epilepsy Res; 2015 Aug; 114():122-30. PubMed ID: 26088895
    [Abstract] [Full Text] [Related]

  • 5. A Phase I, Randomized, Double-Blinded, Placebo- and Moxifloxacin-Controlled, Four-Period Crossover Study To Evaluate the Effect of Gepotidacin on Cardiac Conduction as Assessed by 12-Lead Electrocardiogram in Healthy Volunteers.
    Hossain M, Zhou M, Tiffany C, Dumont E, Darpo B.
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223381
    [Abstract] [Full Text] [Related]

  • 6. Characterization of Neurologic and Ophthalmologic Safety of Oral Administration of Tedizolid for Up to 21 Days in Healthy Volunteers.
    Fang E, Muñoz KA, Prokocimer P.
    Am J Ther; 2017 May; 24(2):e227-e233. PubMed ID: 27941424
    [Abstract] [Full Text] [Related]

  • 7. Ipragliflozin does not prolong QTc interval in healthy male and female subjects: a phase I study.
    Zhang W, Smulders R, Abeyratne A, Dietz A, Krauwinkel W, Kadokura T, Keirns J.
    Clin Ther; 2013 Aug; 35(8):1150-1161.e3. PubMed ID: 23910665
    [Abstract] [Full Text] [Related]

  • 8. Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid.
    Flanagan S, Fang E, Muñoz KA, Minassian SL, Prokocimer PG.
    Pharmacotherapy; 2014 Sep; 34(9):891-900. PubMed ID: 24989138
    [Abstract] [Full Text] [Related]

  • 9. A randomized, placebo- and moxifloxacin-controlled thorough QT study of umeclidinium monotherapy and umeclidinium/vilanterol combination in healthy subjects.
    Kelleher D, Tombs L, Preece A, Brealey N, Mehta R.
    Pulm Pharmacol Ther; 2014 Oct; 29(1):49-57. PubMed ID: 25020273
    [Abstract] [Full Text] [Related]

  • 10. Characterization of the haematological profile of 21 days of tedizolid in healthy subjects.
    Lodise TP, Bidell MR, Flanagan SD, Zasowski EJ, Minassian SL, Prokocimer P.
    J Antimicrob Chemother; 2016 Sep; 71(9):2553-8. PubMed ID: 27317442
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and Safety of Tedizolid after Single and Multiple Intravenous/Oral Sequential Administrations in Healthy Chinese Subjects.
    Chen R, Shen K, Chang X, Tanaka T, Li L, Hu P.
    Clin Ther; 2016 Aug; 38(8):1869-79. PubMed ID: 27461846
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics, Safety and Tolerability of Single Oral or Intravenous Administration of 200 mg Tedizolid Phosphate in Adolescents.
    Bradley JS, Flanagan SD, Arrieta AC, Jacobs R, Capparelli E, Prokocimer P.
    Pediatr Infect Dis J; 2016 Jun; 35(6):628-33. PubMed ID: 26910588
    [Abstract] [Full Text] [Related]

  • 13. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
    Hulhoven R, Rosillon D, Bridson WE, Meeus MA, Salas E, Stockis A.
    Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A Randomized Trial to Assess the Effect of Doravirine on the QTc Interval Using a Single Supratherapeutic Dose in Healthy Adult Volunteers.
    Khalilieh SG, Yee KL, Fan L, Liu R, Heber W, Dunzo E, Triantafyllou I, Hussaini A, Iwamoto M.
    Clin Drug Investig; 2017 Oct; 37(10):975-984. PubMed ID: 28785879
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.